Steven McClellan

2.3k total citations
38 papers, 1.9k citations indexed

About

Steven McClellan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Steven McClellan has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Oncology and 8 papers in Surgery. Recurrent topics in Steven McClellan's work include MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (5 papers) and CRISPR and Genetic Engineering (5 papers). Steven McClellan is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (5 papers) and CRISPR and Genetic Engineering (5 papers). Steven McClellan collaborates with scholars based in United States, China and Switzerland. Steven McClellan's co-authors include Ajay P. Singh, Seema Singh, Jeffrey L. Platt, Arun Bhardwaj, Sanjeev K. Srivastava, John S. Logan, Sumit Arora, Kenneth R. McCurry, Gary A. Piazza and James E. Carter and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Steven McClellan

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven McClellan United States 22 975 567 403 395 310 38 1.9k
Shui Ping Tu China 19 997 1.0× 940 1.7× 343 0.9× 433 1.1× 435 1.4× 23 2.1k
Changcun Guo China 27 1.4k 1.4× 451 0.8× 305 0.8× 582 1.5× 357 1.2× 72 2.3k
Alexei Y. Savinov United States 24 667 0.7× 518 0.9× 327 0.8× 419 1.1× 437 1.4× 45 1.9k
Neveen Said United States 24 803 0.8× 491 0.9× 169 0.4× 397 1.0× 343 1.1× 36 1.8k
Julie Pannequin France 21 945 1.0× 590 1.0× 198 0.5× 344 0.9× 120 0.4× 46 1.7k
Shiqiong Xu China 24 1.2k 1.3× 470 0.8× 181 0.4× 444 1.1× 261 0.8× 51 2.0k
Frédéric Mazurier France 29 1.6k 1.6× 498 0.9× 199 0.5× 457 1.2× 437 1.4× 67 2.8k
Hao Wen China 26 981 1.0× 453 0.8× 279 0.7× 517 1.3× 189 0.6× 103 2.1k
Bingbing Dai United States 28 1.6k 1.6× 590 1.0× 212 0.5× 470 1.2× 269 0.9× 48 2.3k
Ramona Graves‐Deal United States 24 1.6k 1.7× 835 1.5× 168 0.4× 559 1.4× 233 0.8× 33 2.6k

Countries citing papers authored by Steven McClellan

Since Specialization
Citations

This map shows the geographic impact of Steven McClellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven McClellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven McClellan more than expected).

Fields of papers citing papers by Steven McClellan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven McClellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven McClellan. The network helps show where Steven McClellan may publish in the future.

Co-authorship network of co-authors of Steven McClellan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven McClellan. A scholar is included among the top collaborators of Steven McClellan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven McClellan. Steven McClellan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novak, Amanda J, Etienne Danis, Steven McClellan, et al.. (2025). Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia. Cancer Cell. 43(3). 482–502.e9. 3 indexed citations
2.
Niswander, Lisa M, Asen Bagashev, Joseph P. Loftus, et al.. (2024). Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 39(3). 555–567. 3 indexed citations
3.
Niswander, Lisa M, et al.. (2024). Gilteritinib Augments Preclinical FLT3 and CD19 CAR T Cell Immunotherapy in High-Risk Pediatric Leukemias. Blood. 144(Supplement 1). 370–370. 1 indexed citations
4.
Gavin, Elaine, Alla Musiyenko, Wito Richter, et al.. (2022). Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer. Journal of Ovarian Research. 15(1). 120–120. 13 indexed citations
5.
McClellan, Steven, et al.. (2022). PMS2 variant results in loss of ATPase activity without compromising mismatch repair. Molecular Genetics & Genomic Medicine. 10(5). e1908–e1908. 4 indexed citations
6.
Koczor, Christopher A., Joel Andrews, Jennifer Clark, et al.. (2021). Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis. Cell Reports. 37(5). 109917–109917. 44 indexed citations
7.
Khushman, Moh’d, Girijesh Kumar Patel, Javier A. Laurini, et al.. (2019). Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 10(4). 695–702. 24 indexed citations
8.
Liu, Zixing, Wenling Zhang, Joshua B. Phillips, et al.. (2018). Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene. 38(1). 88–102. 83 indexed citations
9.
Slamecka, Jaroslav, Javier A. Laurini, Simon P. Hoerstrup, et al.. (2017). Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions. Journal of Visualized Experiments. 3 indexed citations
10.
Lim, Sangbin, Hao Liu, Luciana Madeira da Silva, et al.. (2016). Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α. Cancer Research. 76(8). 2231–2242. 127 indexed citations
11.
Schmitt, David, Luciana Madeira da Silva, R Arora, et al.. (2015). ErbB2-intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling. Cell Death and Disease. 6(5). e1742–e1742. 30 indexed citations
12.
McClellan, Steven, Jaroslav Slamecka, Lee W. Thompson, et al.. (2015). mRNA detection in living cells: A next generation cancer stem cell identification technique. Methods. 82. 47–54. 29 indexed citations
13.
Tyagi, Nikhil, Saravanakumar Marimuthu, Arun Bhardwaj, et al.. (2015). p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Cancer Letters. 370(2). 260–267. 68 indexed citations
14.
Arora, Sumit, Arun Bhardwaj, Seema Singh, et al.. (2013). An Undesired Effect of Chemotherapy. Journal of Biological Chemistry. 288(29). 21197–21207. 145 indexed citations
15.
Srivastava, Sanjeev K., Anuradha Bhardwaj, Sumit Arora, et al.. (2012). Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance. Carcinogenesis. 33(6). 1149–1157. 46 indexed citations
16.
Liu, Zixing, Hao Liu, Shruti Desai, et al.. (2012). miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance. Journal of Biological Chemistry. 288(6). 4334–4345. 48 indexed citations
17.
Zhang, Jingjing, et al.. (2011). MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death and Differentiation. 19(3). 378–386. 121 indexed citations
18.
McArthur, W. P., Suzanne Stroup, Steven McClellan, & K.‐P. Leung. (1996). Differentiation of the serotype b and species‐specific antigens of Actinobacillus actinomycetemcomitans recognized by monoclonal antibodies. Oral Microbiology and Immunology. 11(4). 209–219. 5 indexed citations
19.
Diamond, Lisa E., et al.. (1996). CHARACTERIZATION OF TRANSGENIC PIGS EXPRESSING FUNCTIONALLY ACTIVE HUMAN CD59 ON CARDIAC ENDOTHELIUM. Transplantation. 61(8). 1241–1249. 127 indexed citations
20.
Kooyman, David L., et al.. (1996). IDENTIFICATION AND CHARACTERIZATION OF A GALACTOSYL PEPTIDE MIMETIC. Transplantation. 61(6). 851–855. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shui Ping Tu Breakdown of academic impact, for papers by Changcun Guo Breakdown of academic impact, for papers by Alexei Y. Savinov Breakdown of academic impact, for papers by Neveen Said Breakdown of academic impact, for papers by Julie Pannequin Breakdown of academic impact, for papers by Shiqiong Xu Breakdown of academic impact, for papers by Frédéric Mazurier Breakdown of academic impact, for papers by Hao Wen Breakdown of academic impact, for papers by Bingbing Dai Breakdown of academic impact, for papers by Ramona Graves‐Deal
Rankless by CCL
2026